login
login

Europe Daily Bulletin No. 9643

16 April 2008
Contents Publication in full By article 39 / 46
GENERAL NEWS / (eu) eu/medicine

15/04/2008 (Agence Europe) - In a press release issued on 14 April, the European Medicines Agency (EMEA) said that the Committee for Orphan Medicinal Products had recommended that eight medicines be designated orphan medicinal products for the treatment of (1) thrombotic thrombocytopenic purpura, (2) congenital alpha-1 antitrypsin deficiency, (3) multiple myeloma, (4) malignant mesothelioma, (5) pancreatic cancer, (6) haemophilia A, (7) haemophilia B, and (8) glioma. More information is...

Contents

A LOOK BEHIND THE NEWS
THE DAY IN POLITICS
GENERAL NEWS